InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Enliven Therapeutics, Inc.

ELVN Clue Score23
United States Fiscal year ends December CIK 0001672619 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

250
Insider
Date
Role
Action
Shares
Price
Amount
Lori Anne Kunkel
30 Oct 2026
Director
Exercised, kept
7,300
$18.30
$133.59K
Lori Anne Kunkel
30 Oct 2026
Director
Exercised, kept
3,741
$1.12
$4.19K
Helen Louise Collins
19 Oct 2026
Chief Medical Officer
Sold after exercise
5,000
$38.47
$192.34K
Benjamin Hohl
19 Oct 2026
Chief Financial Officer
Sold after exercise
6,018
$38.48
$231.55K
J. Scott Garland
1 Oct 2026
Director
Sold after exercise
13,000
$46.67
$606.72K
Helen Louise Collins
17 Sep 2026
Chief Medical Officer
Sold after exercise
240
$51.48
$12.36K
Helen Louise Collins
17 Sep 2026
Chief Medical Officer
Sold after exercise
1,844
$50.71
$93.51K
Helen Louise Collins
17 Sep 2026
Chief Medical Officer
Sold after exercise
2,916
$50.03
$145.89K
Benjamin Hohl
17 Sep 2026
Chief Financial Officer
Sold after exercise
289
$51.49
$14.88K
Benjamin Hohl
17 Sep 2026
Chief Financial Officer
Sold after exercise
2,194
$50.72
$111.27K
Benjamin Hohl
17 Sep 2026
Chief Financial Officer
Sold after exercise
3,535
$50.03
$176.85K
Helen Louise Collins
17 Aug 2026
Chief Medical Officer
Sold after exercise
1,100
$59.35
$65.28K
Helen Louise Collins
17 Aug 2026
Chief Medical Officer
Sold after exercise
3,900
$58.37
$227.65K
Benjamin Hohl
17 Aug 2026
Chief Financial Officer
Sold on a plan
1,388
$59.35
$82.38K
Benjamin Hohl
17 Aug 2026
Chief Financial Officer
Sold on a plan
4,630
$58.35
$270.17K
Mika K Derynck
4 Aug 2026
Director
Sold after exercise
158,795
$60.21
$9.56M
Helen Louise Collins
17 Jul 2026
Chief Medical Officer
Sold after exercise
63
$53.92
$3.40K
Helen Louise Collins
17 Jul 2026
Chief Medical Officer
Sold after exercise
2,184
$53.42
$116.67K
Helen Louise Collins
17 Jul 2026
Chief Medical Officer
Sold after exercise
2,063
$52.39
$108.08K
Helen Louise Collins
17 Jul 2026
Chief Medical Officer
Sold after exercise
459
$51.55
$23.66K
Helen Louise Collins
17 Jul 2026
Chief Medical Officer
Sold after exercise
231
$50.05
$11.56K
Benjamin Hohl
17 Jul 2026
Chief Financial Officer
Sold after exercise
123
$53.87
$6.63K
Benjamin Hohl
17 Jul 2026
Chief Financial Officer
Sold after exercise
2,638
$53.38
$140.82K
Benjamin Hohl
17 Jul 2026
Chief Financial Officer
Sold after exercise
2,564
$52.32
$134.14K
Benjamin Hohl
17 Jul 2026
Chief Financial Officer
Sold after exercise
369
$51.48
$19.00K
Benjamin Hohl
17 Jul 2026
Chief Financial Officer
Sold after exercise
324
$49.97
$16.19K
Lori Anne Kunkel
6 Jul 2026
Director
Sold on a plan
5,889
$50.84
$299.42K
Lori Anne Kunkel
6 Jul 2026
Director
Sold on a plan
4,111
$49.98
$205.48K
Orbimed Advisors LLC
22 Jun 2026
10% owner
Sell indirect
46,776
$45.00
$2.10M
Orbimed Advisors LLC
22 Jun 2026
10% owner
Sell indirect
787,024
$45.38
$35.72M
Orbimed Advisors LLC
22 Jun 2026
10% owner
Sell indirect
1,477
$45.00
$66.47K
Orbimed Advisors LLC
22 Jun 2026
10% owner
Sell indirect
24,846
$45.38
$1.13M
Helen Louise Collins
17 Jun 2026
Chief Medical Officer
Sold after exercise
1,133
$44.74
$50.69K
Helen Louise Collins
17 Jun 2026
Chief Medical Officer
Sold after exercise
2,599
$43.87
$114.02K
Helen Louise Collins
17 Jun 2026
Chief Medical Officer
Sold after exercise
1,268
$42.83
$54.30K
Benjamin Hohl
17 Jun 2026
Chief Financial Officer
Sold after exercise
1,238
$44.75
$55.40K
Benjamin Hohl
17 Jun 2026
Chief Financial Officer
Sold after exercise
3,401
$43.86
$149.18K
Benjamin Hohl
17 Jun 2026
Chief Financial Officer
Sold after exercise
1,379
$42.79
$59.00K
Orbimed Advisors LLC
15 Jun 2026
10% owner
Sell indirect
272,322
$45.02
$12.26M
Orbimed Advisors LLC
15 Jun 2026
10% owner
Sell indirect
9,086
$45.02
$409.05K
Lori Anne Kunkel
5 Jun 2026
Director
Sold on a plan
354
$35.82
$12.68K
Lori Anne Kunkel
5 Jun 2026
Director
Sold on a plan
1,867
$35.36
$66.01K
Lori Anne Kunkel
5 Jun 2026
Director
Sold on a plan
7,779
$34.28
$266.66K
Helen Louise Collins
18 May 2026
Chief Medical Officer
Sold after exercise
223
$41.21
$9.19K
Helen Louise Collins
18 May 2026
Chief Medical Officer
Sold after exercise
1,302
$40.25
$52.40K
Helen Louise Collins
18 May 2026
Chief Medical Officer
Sold after exercise
3,475
$39.53
$137.38K
Helen Louise Collins
17 Apr 2026
Chief Medical Officer
Sold after exercise
2,441
$48.06
$117.30K
Helen Louise Collins
17 Apr 2026
Chief Medical Officer
Sold after exercise
2,419
$47.39
$114.64K
Helen Louise Collins
17 Apr 2026
Chief Medical Officer
Sold after exercise
140
$45.81
$6.41K
Helen Louise Collins
25 Mar 2026
Chief Medical Officer
Sold after exercise
40,000
$35.10
$1.40M
Helen Louise Collins
17 Mar 2026
Chief Medical Officer
Sold after exercise
5,000
$27.76
$138.80K
Helen Louise Collins
10 Mar 2026
Chief Medical Officer
Sold after exercise
10,129
$30.19
$305.83K
Helen Louise Collins
9 Mar 2026
Chief Medical Officer
Sold after exercise
29,871
$30.02
$896.81K
Benjamin Hohl
6 Mar 2026
Chief Financial Officer
Sell
10,000
$29.58
$295.84K
Helen Louise Collins
17 Feb 2026
Chief Medical Officer
Sold after exercise
45,000
$26.17
$1.18M
Richard A. Heyman
17 Feb 2026
Director
Sold on a plan indirect
1,230
$26.18
$32.20K
Joseph P Lyssikatos
6 Feb 2026
Chief Scientific Officer
Sold on a plan indirect
5,000
$29.04
$145.22K
Richard A. Heyman
20 Jan 2026
Director
Sold on a plan indirect
718
$26.96
$19.35K
Richard A. Heyman
20 Jan 2026
Director
Sold on a plan indirect
512
$26.46
$13.55K
Joseph P Lyssikatos
20 Jan 2026
Chief Scientific Officer
Sold on a plan indirect
14,509
$26.90
$390.28K
Joseph P Lyssikatos
20 Jan 2026
Chief Scientific Officer
Sold on a plan indirect
5,491
$26.37
$144.81K
Richard A. Heyman
9 Jan 2026
Director
Sold on a plan indirect
4,285
$25.00
$107.13K
Joseph P Lyssikatos
9 Jan 2026
Chief Scientific Officer
Sold on a plan indirect
50,000
$29.13
$1.46M
Joseph P Lyssikatos
9 Jan 2026
Chief Scientific Officer
Sold on a plan indirect
41,198
$24.90
$1.03M
Anish Patel
9 Jan 2026
Chief Operating Officer
Sold on a plan indirect
243
$28.50
$6.93K
Anish Patel
9 Jan 2026
Chief Operating Officer
Sold on a plan indirect
48,057
$27.98
$1.34M
Richard A. Heyman
8 Jan 2026
Director
Sold on a plan indirect
8,015
$25.04
$200.66K
Richard A. Heyman
8 Jan 2026
Director
Sold on a plan indirect
1,620
$25.00
$40.50K
Joseph P Lyssikatos
8 Jan 2026
Chief Scientific Officer
Sold on a plan indirect
33,802
$24.92
$842.47K
Joseph P Lyssikatos
8 Jan 2026
Chief Scientific Officer
Sold on a plan indirect
7,500
$20.13
$150.96K
Benjamin Hohl
22 Dec 2025
Chief Financial Officer
Exercised, kept
13,000
$2.48
$32.24K
Joseph P Lyssikatos
19 Dec 2025
Chief Scientific Officer
Sold on a plan indirect
5,000
$16.84
$84.21K
Lori Anne Kunkel
17 Dec 2025
Director
Exercised, kept
15,958
$1.12
$17.87K
Anish Patel
8 Dec 2025
Chief Operating Officer
Sold on a plan indirect
1,705
$21.78
$37.13K
Anish Patel
8 Dec 2025
Chief Operating Officer
Sold on a plan indirect
4,958
$20.76
$102.94K
Joseph P Lyssikatos
19 Nov 2025
Chief Scientific Officer
Sold on a plan indirect
492
$23.09
$11.36K
Joseph P Lyssikatos
19 Nov 2025
Chief Scientific Officer
Sold on a plan indirect
12,008
$22.30
$267.79K
Samuel Kintz
17 Nov 2025
President and CEO
Sold on a plan indirect
12,500
$21.82
$272.74K
Anish Patel
7 Nov 2025
Chief Operating Officer
Sold on a plan indirect
613
$17.94
$11.00K
Anish Patel
7 Nov 2025
Chief Operating Officer
Sold on a plan indirect
6,054
$17.35
$105.04K
Joseph P Lyssikatos
20 Oct 2025
Chief Scientific Officer
Sold on a plan indirect
12,500
$22.08
$276.03K
Samuel Kintz
17 Oct 2025
President and CEO
Sold on a plan indirect
12,500
$21.33
$266.65K
Anish Patel
7 Oct 2025
Chief Operating Officer
Sold on a plan indirect
6,667
$20.10
$133.99K
Benjamin Hohl
29 Sep 2025
Chief Financial Officer
Sold after exercise
3,250
$20.40
$66.29K
Samuel Kintz
26 Sep 2025
President and CEO
Sold on a plan indirect
3,700
$20.06
$74.23K
Joseph P Lyssikatos
26 Sep 2025
Chief Scientific Officer
Sold on a plan indirect
4,000
$20.25
$81.01K
Samuel Kintz
23 Sep 2025
President and CEO
Sold on a plan indirect
2,800
$20.03
$56.08K
Joseph P Lyssikatos
23 Sep 2025
Chief Scientific Officer
Sold on a plan indirect
1,500
$20.03
$30.05K
Samuel Kintz
19 Sep 2025
President and CEO
Sold on a plan indirect
1,000
$20.25
$20.25K
Joseph P Lyssikatos
19 Sep 2025
Chief Scientific Officer
Sold on a plan indirect
2,130
$20.02
$42.63K
Joseph P Lyssikatos
19 Sep 2025
Chief Scientific Officer
Sold on a plan indirect
4,870
$19.11
$93.06K
Samuel Kintz
17 Sep 2025
President and CEO
Sold on a plan indirect
5,000
$19.09
$95.47K
Anish Patel
8 Sep 2025
Chief Operating Officer
Sold on a plan indirect
6,667
$20.24
$134.96K
Benjamin Hohl
27 Aug 2025
Chief Financial Officer
Sold after exercise
3,250
$20.63
$67.04K
Joseph P Lyssikatos
21 Aug 2025
Chief Scientific Officer
Sold on a plan indirect
7,500
$20.01
$150.10K
Samuel Kintz
19 Aug 2025
President and CEO
Sold on a plan indirect
590
$20.00
$11.80K
Joseph P Lyssikatos
19 Aug 2025
Chief Scientific Officer
Sold on a plan indirect
5,000
$19.62
$98.12K
Samuel Kintz
18 Aug 2025
President and CEO
Sold on a plan indirect
10,393
$20.02
$208.11K
Anish Patel
7 Aug 2025
Chief Operating Officer
Sold on a plan indirect
405
$18.93
$7.67K
Anish Patel
7 Aug 2025
Chief Operating Officer
Sold on a plan indirect
6,262
$18.20
$113.95K
Benjamin Hohl
28 Jul 2025
Chief Financial Officer
Sold after exercise
65
$21.30
$1.38K
Benjamin Hohl
28 Jul 2025
Chief Financial Officer
Sold after exercise
3,185
$20.45
$65.12K
Joseph P Lyssikatos
21 Jul 2025
Chief Scientific Officer
Sold on a plan indirect
576
$22.90
$13.19K
Joseph P Lyssikatos
21 Jul 2025
Chief Scientific Officer
Sold on a plan indirect
11,924
$22.26
$265.46K
Samuel Kintz
17 Jul 2025
President and CEO
Sold on a plan indirect
3,663
$23.37
$85.61K
Samuel Kintz
17 Jul 2025
President and CEO
Sold on a plan indirect
4,687
$22.69
$106.36K
Samuel Kintz
17 Jul 2025
President and CEO
Sold on a plan indirect
4,150
$21.58
$89.55K
Benjamin Hohl
10 Jul 2025
Chief Financial Officer
Sold after exercise
1,000
$22.66
$22.66K
Anish Patel
7 Jul 2025
Chief Operating Officer
Sold on a plan indirect
305
$20.69
$6.31K
Anish Patel
7 Jul 2025
Chief Operating Officer
Sold on a plan indirect
6,362
$19.75
$125.64K
Benjamin Hohl
27 Jun 2025
Chief Financial Officer
Sold after exercise
198
$21.66
$4.29K
Benjamin Hohl
27 Jun 2025
Chief Financial Officer
Sold after exercise
3,052
$20.86
$63.67K
Joseph P Lyssikatos
20 Jun 2025
Chief Scientific Officer
Sold on a plan indirect
12,500
$21.40
$267.46K
Samuel Kintz
17 Jun 2025
President and CEO
Sold on a plan indirect
1,998
$22.75
$45.45K
Samuel Kintz
17 Jun 2025
President and CEO
Sold on a plan indirect
10,502
$22.08
$231.84K
Benjamin Hohl
13 Jun 2025
Chief Financial Officer
Sold after exercise
3,000
$22.55
$67.66K
Anish Patel
9 Jun 2025
Chief Operating Officer
Sold on a plan indirect
60
$21.16
$1.27K
Anish Patel
9 Jun 2025
Chief Operating Officer
Sold on a plan indirect
6,607
$20.33
$134.30K
Samuel Kintz
3 Jun 2025
President and CEO
Sold on a plan indirect
7,500
$20.05
$150.35K
Joseph P Lyssikatos
3 Jun 2025
Chief Scientific Officer
Sold on a plan indirect
7,500
$20.03
$150.22K
Benjamin Hohl
27 May 2025
Chief Financial Officer
Sold after exercise
3,250
$16.18
$52.59K
Samuel Kintz
19 May 2025
President and CEO
Sold on a plan indirect
5,000
$16.49
$82.45K
Joseph P Lyssikatos
19 May 2025
Chief Scientific Officer
Sold on a plan indirect
5,000
$16.31
$81.53K
Anish Patel
7 May 2025
Chief Operating Officer
Sold on a plan indirect
104
$19.87
$2.07K
Anish Patel
7 May 2025
Chief Operating Officer
Sold on a plan indirect
390
$19.40
$7.57K
Anish Patel
7 May 2025
Chief Operating Officer
Sold on a plan indirect
6,173
$18.30
$112.95K
Samuel Kintz
2 May 2025
President and CEO
Sold on a plan indirect
2,170
$20.00
$43.41K
Joseph P Lyssikatos
2 May 2025
Chief Scientific Officer
Sold on a plan indirect
2,470
$20.01
$49.42K
Samuel Kintz
1 May 2025
President and CEO
Sold on a plan indirect
5,330
$20.08
$107.01K
Joseph P Lyssikatos
1 May 2025
Chief Scientific Officer
Sold on a plan indirect
5,030
$20.07
$100.97K
Benjamin Hohl
28 Apr 2025
Chief Financial Officer
Sold after exercise
69
$19.12
$1.32K
Benjamin Hohl
28 Apr 2025
Chief Financial Officer
Sold after exercise
3,181
$18.68
$59.42K
Joseph P Lyssikatos
21 Apr 2025
Chief Scientific Officer
Sold on a plan indirect
330
$16.72
$5.52K
Joseph P Lyssikatos
21 Apr 2025
Chief Scientific Officer
Sold on a plan indirect
4,670
$16.03
$74.85K
Samuel Kintz
17 Apr 2025
President and CEO
Sold on a plan indirect
5,000
$16.42
$82.10K
Anish Patel
7 Apr 2025
Chief Operating Officer
Sold on a plan indirect
148
$19.27
$2.85K
Anish Patel
7 Apr 2025
Chief Operating Officer
Sold on a plan indirect
2,763
$18.29
$50.53K
Anish Patel
7 Apr 2025
Chief Operating Officer
Sold on a plan indirect
3,756
$17.81
$66.89K
Benjamin Hohl
27 Mar 2025
Chief Financial Officer
Sold after exercise
3,250
$21.33
$69.32K
Benjamin Hohl
24 Mar 2025
Chief Financial Officer
Sold after exercise
1,000
$22.50
$22.50K
Joseph P Lyssikatos
19 Mar 2025
Chief Scientific Officer
Sold on a plan indirect
12,500
$20.61
$257.58K
Samuel Kintz
17 Mar 2025
President and CEO
Sold on a plan indirect
12,500
$20.83
$260.32K
Anish Patel
7 Mar 2025
Chief Operating Officer
Sold on a plan indirect
6,667
$21.44
$142.94K
Benjamin Hohl
4 Mar 2025
Chief Financial Officer
Exercised, kept
10,000
$2.48
$24.80K
Benjamin Hohl
27 Feb 2025
Chief Financial Officer
Sold after exercise
3,250
$20.41
$66.33K
Anish Patel
7 Feb 2025
Chief Operating Officer
Sell indirect
6,667
$21.93
$146.21K
Benjamin Hohl
5 Feb 2025
Chief Financial Officer
Sold after exercise
1,000
$22.52
$22.52K
Benjamin Hohl
27 Jan 2025
Chief Financial Officer
Sold after exercise
3,250
$21.59
$70.18K
Anish Patel
7 Jan 2025
Chief Operating Officer
Sold after exercise indirect
90
$24.60
$2.21K
Anish Patel
7 Jan 2025
Chief Operating Officer
Sold after exercise indirect
6,577
$24.17
$158.96K
Anish Patel
7 Jan 2025
Chief Operating Officer
Sold after exercise
1,440
$24.56
$35.37K
Anish Patel
7 Jan 2025
Chief Operating Officer
Sold after exercise
20,260
$24.15
$489.33K
Benjamin Hohl
3 Jan 2025
Chief Financial Officer
Sold after exercise
1,000
$25.04
$25.04K
Benjamin Hohl
30 Dec 2024
Chief Financial Officer
Sold after exercise
900
$22.51
$20.26K
Benjamin Hohl
27 Dec 2024
Chief Financial Officer
Sold after exercise
3,350
$22.15
$74.22K
Benjamin Hohl
13 Dec 2024
Chief Financial Officer
Exercised, kept
13,000
$2.48
$32.24K
Benjamin Hohl
27 Nov 2024
Chief Financial Officer
Sold after exercise
1,000
$25.38
$25.38K
Benjamin Hohl
27 Nov 2024
Chief Financial Officer
Sold after exercise
4,250
$24.78
$105.31K
Benjamin Hohl
28 Oct 2024
Chief Financial Officer
Sold after exercise
650
$29.11
$18.92K
Benjamin Hohl
28 Oct 2024
Chief Financial Officer
Sold after exercise
5,600
$28.49
$159.56K
Helen Louise Collins
18 Oct 2024
Chief Medical Officer
Sold after exercise
816
$30.00
$24.48K
Richard A. Heyman
18 Oct 2024
Director
Sold on a plan indirect
753
$30.00
$22.59K
Richard A. Heyman
18 Oct 2024
Director
Sold on a plan
817
$30.00
$24.51K
Benjamin Hohl
18 Oct 2024
Chief Financial Officer
Sold after exercise
814
$30.00
$24.42K
Samuel Kintz
18 Oct 2024
President and CEO
Sold on a plan indirect
924
$30.00
$27.72K
Joseph P Lyssikatos
18 Oct 2024
Chief Scientific Officer
Sold on a plan indirect
847
$30.00
$25.41K
Anish Patel
18 Oct 2024
Chief Operating Officer
Sold on a plan indirect
716
$30.00
$21.48K
Richard A. Heyman
15 Oct 2024
Director
Sold on a plan
1,270
$27.67
$35.14K
Samuel Kintz
9 Oct 2024
President and CEO
Sold on a plan indirect
2,830
$28.53
$80.73K
Samuel Kintz
9 Oct 2024
President and CEO
Sold on a plan indirect
13,880
$28.07
$389.68K
Joseph P Lyssikatos
9 Oct 2024
Chief Scientific Officer
Sold on a plan indirect
3,589
$28.52
$102.36K
Joseph P Lyssikatos
9 Oct 2024
Chief Scientific Officer
Sold on a plan indirect
34,289
$28.12
$964.20K
Rahul D. Ballal
8 Oct 2024
Director
Sold after exercise
10,420
$28.17
$293.56K
Samuel Kintz
8 Oct 2024
President and CEO
Sold on a plan indirect
100
$28.51
$2.85K
Samuel Kintz
8 Oct 2024
President and CEO
Sold on a plan indirect
13,167
$27.95
$368.08K
Joseph P Lyssikatos
8 Oct 2024
Chief Scientific Officer
Sold on a plan indirect
100
$28.51
$2.85K
Joseph P Lyssikatos
8 Oct 2024
Chief Scientific Officer
Sold on a plan indirect
13,167
$27.96
$368.17K
Benjamin Hohl
7 Oct 2024
Chief Financial Officer
Sold after exercise
1,270
$27.51
$34.94K
Samuel Kintz
7 Oct 2024
President and CEO
Sold on a plan indirect
2,730
$27.50
$75.08K
Joseph P Lyssikatos
7 Oct 2024
Chief Scientific Officer
Sold on a plan indirect
2,707
$27.61
$74.73K
Richard A. Heyman
4 Oct 2024
Director
Sold on a plan
2,825
$27.51
$77.70K
Benjamin Hohl
4 Oct 2024
Chief Financial Officer
Sold after exercise
10,218
$27.51
$281.08K
Samuel Kintz
4 Oct 2024
President and CEO
Sold on a plan indirect
12,206
$27.51
$335.79K
Joseph P Lyssikatos
4 Oct 2024
Chief Scientific Officer
Sold on a plan indirect
7,522
$27.51
$206.94K
Richard A. Heyman
1 Oct 2024
Director
Sold on a plan
518
$27.54
$14.26K
Benjamin Hohl
1 Oct 2024
Chief Financial Officer
Sold after exercise
521
$27.54
$14.35K
Samuel Kintz
1 Oct 2024
President and CEO
Sold on a plan indirect
526
$27.54
$14.48K
Joseph P Lyssikatos
1 Oct 2024
Chief Scientific Officer
Sold on a plan indirect
527
$27.54
$14.51K
Benjamin Hohl
30 Sep 2024
Chief Financial Officer
Sold after exercise
2,000
$25.33
$50.67K
Benjamin Hohl
27 Sep 2024
Chief Financial Officer
Sold after exercise
4,250
$24.27
$103.16K
Richard A. Heyman
16 Sep 2024
Director
Sold on a plan
1,270
$22.41
$28.46K
Joseph P Lyssikatos
29 Aug 2024
Chief Scientific Officer
Sold on a plan indirect
50
$23.08
$1.15K
Joseph P Lyssikatos
29 Aug 2024
Chief Scientific Officer
Sold on a plan indirect
11,950
$22.48
$268.69K
Benjamin Hohl
27 Aug 2024
Chief Financial Officer
Sold after exercise
4,250
$22.54
$95.78K
Samuel Kintz
26 Aug 2024
President and CEO
Sold on a plan indirect
12,000
$22.89
$274.72K
Richard A. Heyman
15 Aug 2024
Director
Sold on a plan
620
$23.70
$14.70K
Richard A. Heyman
15 Aug 2024
Director
Sold on a plan
650
$22.82
$14.83K
Richard A. Heyman
31 Jul 2024
Director
Sold on a plan indirect
649
$27.50
$17.85K
Richard A. Heyman
31 Jul 2024
Director
Sold on a plan
1,702
$27.51
$46.82K
Benjamin Hohl
31 Jul 2024
Chief Financial Officer
Sold after exercise
991
$27.53
$27.28K
Samuel Kintz
31 Jul 2024
President and CEO
Sold on a plan indirect
2,270
$27.56
$62.56K
Joseph P Lyssikatos
31 Jul 2024
Chief Scientific Officer
Sold on a plan indirect
3,099
$27.56
$85.40K
Benjamin Hohl
29 Jul 2024
Chief Financial Officer
Sold after exercise
61
$27.44
$1.67K
Benjamin Hohl
29 Jul 2024
Chief Financial Officer
Sold after exercise
5,189
$26.67
$138.38K
Joseph P Lyssikatos
29 Jul 2024
Chief Scientific Officer
Sold on a plan indirect
203
$27.43
$5.57K
Joseph P Lyssikatos
29 Jul 2024
Chief Scientific Officer
Sold on a plan indirect
11,797
$26.69
$314.81K
Samuel Kintz
25 Jul 2024
President and CEO
Sold on a plan indirect
43
$25.83
$1.11K
Samuel Kintz
25 Jul 2024
President and CEO
Sold on a plan indirect
8,164
$25.10
$204.92K
Samuel Kintz
25 Jul 2024
President and CEO
Sold on a plan indirect
3,793
$24.53
$93.04K
Anish Patel
16 Jul 2024
Chief Operating Officer
Sold on a plan indirect
1,547
$25.01
$38.69K
Anish Patel
15 Jul 2024
Chief Operating Officer
Sold on a plan indirect
30,978
$25.05
$776.04K
Richard A. Heyman
15 Jul 2024
Director
Sold on a plan
1,270
$24.80
$31.50K
Benjamin Hohl
12 Jul 2024
Chief Financial Officer
Sold after exercise
3,000
$25.07
$75.20K
Anish Patel
12 Jul 2024
Chief Operating Officer
Sold on a plan indirect
17,475
$25.07
$438.09K
Joseph P Lyssikatos
1 Jul 2024
Chief Scientific Officer
Sold on a plan indirect
12,000
$22.89
$274.74K
Benjamin Hohl
27 Jun 2024
Chief Financial Officer
Sold after exercise
1,140
$23.43
$26.71K
Benjamin Hohl
27 Jun 2024
Chief Financial Officer
Sold after exercise
1,830
$22.58
$41.31K
Benjamin Hohl
27 Jun 2024
Chief Financial Officer
Sold after exercise
1,280
$21.79
$27.90K
Samuel Kintz
25 Jun 2024
President and CEO
Sold on a plan indirect
578
$22.30
$12.89K
Samuel Kintz
25 Jun 2024
President and CEO
Sold on a plan indirect
11,422
$21.63
$247.01K
Richard A. Heyman
17 Jun 2024
Director
Sold on a plan
1,270
$21.48
$27.28K
Anish Patel
6 Jun 2024
Chief Operating Officer
Sold after exercise
1,133
$20.06
$22.72K
Joseph P Lyssikatos
29 May 2024
Chief Scientific Officer
Sold after exercise
2,123
$22.52
$47.81K
Joseph P Lyssikatos
29 May 2024
Chief Scientific Officer
Sold after exercise
9,877
$21.56
$212.99K
Benjamin Hohl
28 May 2024
Chief Financial Officer
Sold after exercise
10
$24.34
$243.40
Benjamin Hohl
28 May 2024
Chief Financial Officer
Sold after exercise
2,334
$23.42
$54.66K
Benjamin Hohl
28 May 2024
Chief Financial Officer
Sold after exercise
1,906
$22.89
$43.63K
Samuel Kintz
28 May 2024
President and CEO
Sold after exercise
100
$24.34
$2.43K
Samuel Kintz
28 May 2024
President and CEO
Sold after exercise
5,219
$23.57
$123.02K
Samuel Kintz
28 May 2024
President and CEO
Sold after exercise
6,681
$22.86
$152.76K
Orbimed Advisors LLC
16 May 2024
Director
Sell indirect
1,000,000
$22.14
$22.14M
Orbimed Advisors LLC
16 May 2024
Director
Sell indirect
33,300
$22.14
$737.26K
Rishi Gupta
16 May 2024
Director
Sell indirect
1,000,000
$22.14
$22.14M
Rishi Gupta
16 May 2024
Director
Sell indirect
33,300
$22.14
$737.26K
Richard A. Heyman
16 May 2024
Director
Sold on a plan
1,270
$23.74
$30.15K
Anish Patel
14 May 2024
Chief Operating Officer
Sold after exercise
1,107
$25.00
$27.68K
Anish Patel
9 May 2024
Chief Operating Officer
Sold after exercise
260
$25.06
$6.52K
Anish Patel
6 May 2024
Chief Operating Officer
Sold after exercise
4,875
$22.72
$110.77K
Benjamin Hohl
3 May 2024
Chief Financial Officer
Sold after exercise
1,000
$22.50
$22.50K
Benjamin Hohl
29 Apr 2024
Chief Financial Officer
Sold after exercise
3,250
$16.97
$55.16K
Joseph P Lyssikatos
29 Apr 2024
Chief Scientific Officer
Sold after exercise
1,013
$18.48
$18.72K
Joseph P Lyssikatos
29 Apr 2024
Chief Scientific Officer
Sold after exercise
10,987
$17.86
$196.27K
Samuel Kintz
25 Apr 2024
President and CEO
Sold after exercise
12,000
$16.89
$202.70K
Richard A. Heyman
15 Apr 2024
Director
Sold on a plan
80
$20.68
$1.65K
Richard A. Heyman
15 Apr 2024
Director
Sold on a plan
1,190
$19.94
$23.73K
Rahul D. Ballal
11 Apr 2024
Director
Sold after exercise
3,068
$25.21
$77.34K
Rahul D. Ballal
11 Apr 2024
Director
Sold after exercise
20,032
$25.00
$500.70K
Rahul D. Ballal
11 Apr 2024
Director
Sold after exercise
30,300
$23.14
$701.02K
Helen Louise Collins
11 Apr 2024
Chief Medical Officer
Sold after exercise
20,000
$25.07
$501.48K
Richard A. Heyman
11 Apr 2024
Director
Sold on a plan indirect
649
$25.00
$16.23K
Showing 250 of 414 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 327
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 32
Sales on a Rule 10b5-1 plan 150
Sales straight out of an exercise 150
Sales at will 64
Transactions with no price 0
Shares from compensation/vesting 45,234,647
Sales filed before the plan box existed 44
History held since 16 Mar 2020